Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns naming Colm Burke .
Filed returns
1,221
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| May–Aug 2021 | Autism Spectrum Information, Advice and Meeting Point Ltd, Trading as AsIAm | Health | Wrote to members of the Joint Oireachtas Committee on Health regarding our Every Child Counts report into autistic children accessing HSE supports (Public policy or programme) | 14 | On lobbying.ie |
| Jan–Apr 2021 | Health Research Charities Ireland | Health | HRCI 2021 position paper: Renewal through health research (Public policy or programme) | 20 | On lobbying.ie |
| Jan–Apr 2021 | Transgender Equality Network Ireland | Health | Discussion on Transgender Healthcare for young people (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2021 | Irish Council for Civil Liberties | Health | Collection and Retention of Personal Data Pertaining to Autistic Children Taking Legal Action Against the State. (Public policy or programme) | 23 | On lobbying.ie |
| Jan–Apr 2021 | Vertex Pharmaceuticals (Europe) Limited | Health | Cystic Fibrosis landscape in Ireland (Matters involving public funds) | 15 | On lobbying.ie |
| Jan–Apr 2021 | Alcohol Awareness Foundation Limited | Health | Letters sharing Drinkaware's MUP Explainer for the general public as an FYI (Public policy or programme) | 24 | On lobbying.ie |
| Jan–Apr 2021 | Hanover Media Strategy Limited | Health | Update on COVID-19 Vaccine AstraZeneca (Public policy or programme) | 15 | On lobbying.ie |
| Jan–Apr 2021 | Hanover Media Strategy Limited | Health | Treatment of Irish patients with Amyloidosis in Ireland and reimbursement pathway for Alnylam medicines (Matters involving public funds) | 15 | On lobbying.ie |
| Jan–Apr 2021 | MSD | Health | Oncology Policy (Public policy or programme) | 9 | On lobbying.ie |
| Jan–Apr 2021 | Home and Community Care Ireland | Health | Covid-19 issues in the home care sector (Public policy or programme) | 4 | On lobbying.ie |
| Jan–Apr 2021 | Irish Medical Organisation | Health | COVID 19 - Protection and support for frontline health care workers (Public policy or programme) | 14 | On lobbying.ie |
| Jan–Apr 2021 | FTI Consulting | Health | GW Pharmaceuticals met with David Cullinane TD and Colm Burke TD, in the context of their membership of the Oireachtas Health Committee, to discuss cannabinoid science and GW Pharmaceuticals. (Public policy or programme) | 2 | On lobbying.ie |
| Jan–Apr 2021 | JKS Communications | Health | reimbursement for gene therapy for rare degenerative eye disease (Matters involving public funds) | 9 | On lobbying.ie |
| Jan–Apr 2021 | Inclusion Ireland | Health | Data Protection & Consent (Public policy or programme) | 16 | On lobbying.ie |
| Jan–Apr 2021 | NCBI | Health | The expansion of the Eye Clinic Liaison Officer Service (ECLO's) to acute hospitals outside of Dublin (Public policy or programme) | 23 | On lobbying.ie |
| Jan–Apr 2021 | NCBI | Health | The expansion of the Eye Clinic Liaison Officer Service (ECLO's) to acute hospitals outside of Dublin (Public policy or programme) | 28 | On lobbying.ie |
| Jan–Apr 2021 | Irish Dental Association | Health | Correspondence re delay in vaccination of dentists plus their potential participation as vaccinators (Public policy or programme) | 2 | On lobbying.ie |
| Jan–Apr 2021 | Irish Dental Association | Health | Problems with Dental Treatment Services Scheme (Public policy or programme) | 12 | On lobbying.ie |
| Jan–Apr 2021 | Nursing Homes Ireland | Health | To ask the Minister for Health the expenditure incurred for HSE nursing homes in the management of Covid19 to date; the geographical distribution of the funding; the number of HSE nursing homes that have received… (Matters involving public funds) | 2 | On lobbying.ie |
| Jan–Apr 2021 | Nursing Homes Ireland | Health | Presentation of NHI's submission of the Atypical Working Scheme to advocate on behalf of members articulating workforce challenges and recruitment obstacles presenting in our sector (Legislation) | 3 | On lobbying.ie |
| Jan–Apr 2021 | Sage Advocacy | Health | Covid-19 & Adult Day Centres: To ascertain when adult day centres, which enable older people to retain their independence and continue living in their own communities, will reopen? (Matters involving public funds) | 3 | On lobbying.ie |
| Jan–Apr 2021 | Irish Pharmaceutical Healthcare Association | Health | Access to new medicines (Public policy or programme) | 2 | On lobbying.ie |
| Jan–Apr 2021 | Irish Pharmaceutical Healthcare Association | Health | Extension of framework agreement on medicines. (Public policy or programme) | 14 | On lobbying.ie |
| Jan–Apr 2021 | Respect Vapers | Health | Legislation on vaping products (Legislation) | 53 | On lobbying.ie |
| Jan–Apr 2021 | Irish Hospital Consultants Association | Health | Committee Hearing on Protection and Support of Frontline Health Care Workers (Matters involving public funds) | 14 | On lobbying.ie |
| Jan–Apr 2021 | Irish Cancer Society | Health | Oireachtas Cross-Party Group on Cancer (Public policy or programme) | 19 | On lobbying.ie |
| Jan–Apr 2021 | Irish Kidney Association | Health | Priorities on Vaccination (Public policy or programme) | 8 | On lobbying.ie |
| Jan–Apr 2021 | Vulcan Consulting Limited | Health | Rare disease policy in Ireland (Public policy or programme) | 8 | On lobbying.ie |
| Jan–Apr 2021 | Sage Advocacy | Health | To share a discussion document with elected representatives to highlight key long term care issues in Ireland and to suggest a policy action framework for an alternative model of long-term support and care which could… (Matters involving public funds) | 13 | On lobbying.ie |
| Jan–Apr 2021 | Sage Advocacy | Health | Covid 19 & Nursing Homes: To raise issues of concern highlighted by nursing home residents and their families and noted by Sage Advocacy through its work, with government representatives. (Matters involving public funds) | 5 | On lobbying.ie |
| Jan–Apr 2021 | BeLonG To Youth Services Ltd. | Health | Access to healthcare for Trans young people in Ireland. (Public policy or programme) | 9 | On lobbying.ie |
| Jan–Apr 2021 | Hanover Media Strategy Limited | Health | Creation of national policy with regard to Orphan Medicinal Products (Legislation) | 9 | On lobbying.ie |
| Jan–Apr 2021 | The Irish Society for Autism | Health | The impact of Covid 19 and the need for autism specific legislation (Legislation) | 55 | On lobbying.ie |
| Jan–Apr 2021 | Alcohol Action Ireland | Health | Mid term review of National Drugs Strategy – Reducing Harm, Supporting Recovery (Public policy or programme) | 9 | On lobbying.ie |
| Jan–Apr 2021 | Limelight Communications | Health | Issues pertinent to older around health, loneliness, housing. (Public policy or programme) | 53 | On lobbying.ie |
| Jan–Apr 2021 | Irish Heart Foundation | Health | COVID-19 Vaccine Rollout Priority List (Public policy or programme) | 9 | On lobbying.ie |
| Jan–Apr 2021 | Fórsa trade union | Health | Asked certain TDs, Senators and Councillor to attend a Fórsa briefing in May on the health sector. (Public policy or programme) | 17 | On lobbying.ie |
| Jan–Apr 2021 | Hume Brophy | Health | Governance review of drugs approval and procurement process (Matters involving public funds) | 12 | On lobbying.ie |
| Jan–Apr 2021 | ALONE | Health | Discussion on establishing a National Subgroup and re-emergence plan for older people and other vulnerable groups, Housing with Support for older people, home care regulation and to inform about ALONE's work (Public policy or programme) | 7 | On lobbying.ie |
| Jan–Apr 2021 | Neurological Alliance of Ireland | Health | Implementation of National Neurorehabilitation Strategy Framework 2019-2021 and investment to support its implementation (Public policy or programme) | 31 | On lobbying.ie |
| Jan–Apr 2021 | Fighting Blindness | Health | The HSE reimbursement of gene therapy 'Luxturna' (Matters involving public funds) | 5 | On lobbying.ie |
| Jan–Apr 2021 | BioMarin International Limited | Health | Rare disease policy in Ireland (Public policy or programme) | 6 | On lobbying.ie |
| Jan–Apr 2021 | ALONE | Health | Email requesting a meeting to discuss developing a plan to support older people and vulnerable cohorts re-emerging into society post-COVID (Legislation) | 14 | On lobbying.ie |
| Jan–Apr 2021 | Illumina Cambridge Ltd | Health | Provided an introduction to Illumina and the company's footprint in Ireland and gave an overview of the value of genomics in healthcare and agriculture. (Public policy or programme) | 13 | On lobbying.ie |
| Sep–Dec 2020 | Rare Diseases Ireland | Health | Rare disease health policy in programme for government (Public policy or programme) | 14 | On lobbying.ie |
| Sep–Dec 2020 | National Disability Services Association | Health | Submissions to members of new Oireachtas Committees on the National Disability Services Association (Public policy or programme) | 36 | On lobbying.ie |
| Sep–Dec 2020 | Epilepsy Ireland | Health | Providing information on Sodium Valproate and seeking a meeting to discuss ongoing issues surrounding Sodium Valproate. Seeking that the new Health Committee hold a new hearing on issue. (Public policy or programme) | 12 | On lobbying.ie |
| Sep–Dec 2020 | Arthritis Ireland | Health | Provision of rheumatology services within the health service (Matters involving public funds) | 14 | On lobbying.ie |
| Sep–Dec 2020 | Nursing Homes Ireland | Health | Engagement with Senator re challenges faced by the nursing home sector during COVID-19 pandemic (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2020 | Abbvie Limited | Health | Health Policy engagements (Public policy or programme) | 11 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 1,221 | 100.0% |